Trials / Completed
CompletedNCT01993732
Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function
Ovarian Tissue Cryopreservation As A Means Of Preserving Ovarian Function in Females Undergoing Therapeutic Procedures That Will Potentially Lead To The Irreversible Loss of Ovarian Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- Female
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to retrieve and cryopreserve ovarian tissue from females undergoing a treatment that may lead to irreversible loss of ovarian function.
Detailed description
The aim of this preliminary study is to retrieve and properly cryopreserve ovarian tissue for autotransplantation in any premenopausal female whose ovarian function is threatened in a physiological, pathological or iatrogenic manner in an effort to observe the return of ovarian endocrine function and development of egg(s) appropriate for use in in vitro fertilization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Retrieval and Cryopreservation | Females undergoing therapeutic procedures that will potentially lead to the irreversible loss of ovarian function will have their ovarian tissue retrieved and cryopreserved. Ideally, after treatment, the cryopreserved ovarian tissue can be thawed and auto-transplanted and ovarian function resumed. |
Timeline
- Start date
- 2013-08-06
- Primary completion
- 2018-06-28
- Completion
- 2018-06-28
- First posted
- 2013-11-25
- Last updated
- 2019-08-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01993732. Inclusion in this directory is not an endorsement.